These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9171214)

  • 41. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 2003 Aug; 35(8 Suppl):8-9. PubMed ID: 12964303
    [No Abstract]   [Full Text] [Related]  

  • 42. False-positive cannabis results in Italian workplace drug testing.
    Fucci N; De Giovanni N
    Drug Test Anal; 2012 Feb; 4(2):71-3. PubMed ID: 22362572
    [No Abstract]   [Full Text] [Related]  

  • 43. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine.
    Wennig R; Moeller MR; Haguenoer JM; Marocchi A; Zoppi F; Smith BL; de la Torre R; Carstensen CA; Goerlach-Graw A; Schaeffler J; Leinberger R
    J Anal Toxicol; 1998; 22(2):148-55. PubMed ID: 9547412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
    Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crisis in drug testing. Results of CDC blind study.
    Hansen HJ; Caudill SP; Boone DJ
    JAMA; 1985 Apr; 253(16):2382-7. PubMed ID: 2984441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of CEDIA and DRI Drugs of Abuse Immunoassays for Urine Screening on a Thermo Indiko Plus Analyzer.
    Köhler KM; Hammer R; Riedy K; Auwärter V; Neukamm MA
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27346579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dilution of urine drug tests: is it random?
    Price JW
    J Addict Med; 2013; 7(6):405-9. PubMed ID: 24104191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multianalyte assay system developed for drugs of abuse.
    Parsons RG; Kowal R; LeBlond D; Yue VT; Neargarder L; Bond L; Garcia D; Slater D; Rogers P
    Clin Chem; 1993 Sep; 39(9):1899-903. PubMed ID: 8375068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adulterants and drugs-of- abuse testing: an update.
    Dasgupta A
    MLO Med Lab Obs; 2008 Feb; 40(2):24-5. PubMed ID: 18405221
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
    Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
    Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Psychoactive substances in biological samples--toxicological laboratory data].
    Gomółka E; Wilimowska J; Piekoszewski W; Groszek B
    Przegl Lek; 2004; 61(4):323-7. PubMed ID: 15521594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Uniform analyzes of drugs in urine needed for rule of law].
    Hansson T; Helander A; Beck O; Elmgren A; Kugelberg F; Kronstrand R
    Lakartidningen; 2015 Sep; 112():. PubMed ID: 26393972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone.
    de Jager AD; Bailey NL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2642-52. PubMed ID: 21839693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphetamine, cocaine and cannabinoids use among truck drivers on the roads in the State of Sao Paulo, Brazil.
    Leyton V; Sinagawa DM; Oliveira KC; Schmitz W; Andreuccetti G; De Martinis BS; Yonamine M; Munoz DR
    Forensic Sci Int; 2012 Feb; 215(1-3):25-7. PubMed ID: 21511416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug screening with EMIT reagents: a quantitative approach to quality control.
    Standefer JC; Backer RC
    Clin Chem; 1991 May; 37(5):733-8. PubMed ID: 2032329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
    Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
    J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.